Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 2
2021 4
2022 22
2023 15
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Results by year

Filters applied: . Clear all
Page 1
Proposed New Dynamic Prognostic Index for Diffuse Large B-Cell Lymphoma: International Metabolic Prognostic Index.
Mikhaeel NG, Heymans MW, Eertink JJ, de Vet HCW, Boellaard R, Dührsen U, Ceriani L, Schmitz C, Wiegers SE, Hüttmann A, Lugtenburg PJ, Zucca E, Zwezerijnen GJC, Hoekstra OS, Zijlstra JM, Barrington SF. Mikhaeel NG, et al. Among authors: zwezerijnen gjc. J Clin Oncol. 2022 Jul 20;40(21):2352-2360. doi: 10.1200/JCO.21.02063. Epub 2022 Mar 31. J Clin Oncol. 2022. PMID: 35357901 Free PMC article.
Folate Receptor Beta for Macrophage Imaging in Rheumatoid Arthritis.
Steinz MM, Ezdoglian A, Khodadust F, Molthoff CFM, Srinivasarao M, Low PS, Zwezerijnen GJC, Yaqub M, Beaino W, Windhorst AD, Tas SW, Jansen G, van der Laken CJ. Steinz MM, et al. Among authors: zwezerijnen gjc. Front Immunol. 2022 Feb 2;13:819163. doi: 10.3389/fimmu.2022.819163. eCollection 2022. Front Immunol. 2022. PMID: 35185910 Free PMC article. Review.
An artificial intelligence method using FDG PET to predict treatment outcome in diffuse large B cell lymphoma patients.
Ferrández MC, Golla SSV, Eertink JJ, de Vries BM, Lugtenburg PJ, Wiegers SE, Zwezerijnen GJC, Pieplenbosch S, Kurch L, Hüttmann A, Hanoun C, Dührsen U, de Vet HCW; PETRA; Zijlstra JM, Boellaard R. Ferrández MC, et al. Among authors: zwezerijnen gjc. Sci Rep. 2023 Aug 12;13(1):13111. doi: 10.1038/s41598-023-40218-1. Sci Rep. 2023. PMID: 37573446 Free PMC article.
[89Zr]Zr-DFO-girentuximab and [18F]FDG PET/CT to Predict Watchful Waiting Duration in Patients with Metastatic Clear-cell Renal Cell Carcinoma.
Verhoeff SR, Oosting SF, Elias SG, van Es SC, Gerritse SL, Angus L, Heskamp S, Desar IME, Menke-van der Houven van Oordt CW, van der Veldt AAM, Arens AIJ, Brouwers AH, Eisses B, Mulders PFA, Hoekstra OS, Zwezerijnen GJC, van der Graaf WTA, Aarntzen EHJG, Oyen WJG, van Herpen CML. Verhoeff SR, et al. Among authors: zwezerijnen gjc. Clin Cancer Res. 2023 Feb 1;29(3):592-601. doi: 10.1158/1078-0432.CCR-22-0921. Clin Cancer Res. 2023. PMID: 36394882 Free PMC article.
PET-CT Imaging of Polymeric Nanoparticle Tumor Accumulation in Patients.
Miedema IHC, Zwezerijnen GJC, Huisman MC, Doeleman E, Mathijssen RHJ, Lammers T, Hu Q, van Dongen GAMS, Rijcken CJF, Vugts DJ, Menke-van der Houven van Oordt CW. Miedema IHC, et al. Among authors: zwezerijnen gjc. Adv Mater. 2022 May;34(21):e2201043. doi: 10.1002/adma.202201043. Epub 2022 Apr 25. Adv Mater. 2022. PMID: 35427430
39 results